Compassionate Use of Evinacumab
NCT06500598 · Status: APPROVED_FOR_MARKETING · Type: EXPANDED_ACCESS
Last updated 2025-10-28
Summary
Provide compassionate use of evinacumab
Conditions
- Pediatric Homozygous Familial Hypercholesterolemia (HoFH)
- Severe Hypertriglyceridemia (HTG)
- Dysbetalipoproteinemia (DBL)
Interventions
- DRUG
-
Evinacumab
Sponsors & Collaborators
- lead INDUSTRY
Eligibility
- Sex
- Healthy Volunteers
- No
Timeline & Regulatory
More Related Trials
-
Expanded Access of Ruxolitinib Cream to Treat a Single Patient With cGVHD
NCT05722912 ·Status: APPROVED_FOR_MARKETING
-
Study of Pregnyl as Adjunct Therapy for High-Risk or Refractory Acute GVHD
NCT02525029 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Study of Efficacy and Safety of Canakinumab in Pediatric Patients With Kawasaki Disease
NCT02980263 ·Status: WITHDRAWN ·Phase: PHASE2
-
Expanded Access of Axatilimab to Treat a Single Patient With Chronic Graft Versus Host Disease (GVHD)
NCT05544032 ·Status: AVAILABLE
-
Safety and Efficacy of Efavaleukin Alfa in Subjects With Steroid Refractory Chronic Graft Versus Host Disease
NCT03422627 ·Status: TERMINATED ·Phase: PHASE1/PHASE2
-
Abatacept to Treat Steroid Refractory Chronic Graft Versus Host Disease (cGVHD)
NCT01954979 ·Status: COMPLETED ·Phase: PHASE1
-
Efficacy and Safety of Efalizumab in the Treatment of Moderate-Severe Hydradenitis Suppurativa
NCT00134134 ·Status: COMPLETED ·Phase: PHASE1
-
Pharmacokinetics, Safety, and Efficacy of Povorcitinib in Adolescent Participants With Moderate to Severe Hidradenitis Suppurativa
NCT07213973 ·Status: RECRUITING ·Phase: PHASE2
-
Ibrutinib in Combination With Corticosteroids vs Placebo in Combination With Corticosteroids in Participants With New Onset Chronic Graft Versus Host Disease (cGVHD)
NCT02959944 ·Status: COMPLETED ·Phase: PHASE3
-
Study of BHV-1400 in IgA Nephropathy
NCT07054684 ·Status: RECRUITING ·Phase: PHASE1
-
Evaluate the Safety and Efficacy of Canakinumab in Pediatric Patients With Colchicine Intolerant or Colchicine Resistant Familial Mediterranean Fever (FMF)
NCT01148797 ·Status: COMPLETED ·Phase: PHASE2
-
Individual Patient Compassionate Use of Mirdametinib
NCT05028166 ·Status: AVAILABLE
-
Itacitinib for Low Risk GVHD
NCT03846479 ·Status: COMPLETED ·Phase: PHASE2
-
Compassionate Use of Pozelimab and Cemdisiran Combination Therapy in Patients With Paroxysmal Nocturnal Hemoglobinuria
NCT06028594 ·Status: NO_LONGER_AVAILABLE
-
Etanercept in Treating Young Patients With Idiopathic Pneumonia Syndrome After Undergoing a Donor Stem Cell Transplant
NCT00309907 ·Status: COMPLETED ·Phase: PHASE2
-
Ibrutinib and Rituxan for Chronic GVHD
NCT04235036 ·Status: TERMINATED ·Phase: PHASE2
-
Infliximab and Basiliximab for Treatment of Steroid Refractory Acute Graft Versus Host Disease
NCT01485055 ·Status: TERMINATED ·Phase: PHASE2
-
A Study of Eltrekibart (LY3041658) in Adult Participants With Moderate to Severe Hidradenitis Suppurativa
NCT06046729 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Belimumab for Prevention of Chronic Graft-versus-Host Disease Following Allogeneic Hematopoietic Cell Transplantation
NCT03207958 ·Status: COMPLETED ·Phase: PHASE1
-
A Single-arm, Dose-escalation Trial of Long-acting Recombinant Human IL-7 (NT-I7, Efineptakin Alfa) for Idiopathic CD4 Lymphopenia
NCT05600920 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
A Study of the Bruton's Tyrosine Kinase (BTK) Inhibitor Ibrutinib in Participants With Steroid Dependent/Refractory Chronic Graft Versus Host Disease (cGVHD)
NCT03474679 ·Status: COMPLETED ·Phase: PHASE3
-
Use of Immune Globulin Plus Rituximab for Desensitization in Highly HLA Sensitized Patients Awaiting Deceased Donor Kidney Transplantation
NCT01178216 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Efficacy and Safety of Obinutuzumab Versus Rituximab in Childhood Steroid Dependant and Frequent Relapsing Nephrotic Syndrome
NCT05786768 ·Status: RECRUITING ·Phase: PHASE2/PHASE3
-
Subcutaneous Pharmacokinetics of Belatacept
NCT00569803 ·Status: COMPLETED ·Phase: PHASE1
-
Subcutaneous Treatment With Icatibant for Acute Attacks of Hereditary Angioedema
NCT00097695 ·Status: COMPLETED ·Phase: PHASE3